Local failure patterns after radical resection and adjuvant chemotherapy in patients with pN2 nonsmall-cell lung cancer: A retrospective analysis

被引:3
|
作者
Wang, Chenyu [1 ]
Li, Haixia [1 ]
Chen, Yongshun [2 ]
Ge, Hong [1 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Peoples R China
关键词
Nodal recurrence; nonsmall cell lung cancer; pN2; postoperative radiotherapy; VINORELBINE PLUS CISPLATIN; POSTOPERATIVE RADIOTHERAPY; TARGET VOLUME; STAGE-I; THERAPY; SURVIVAL;
D O I
10.4103/ijc.IJC_691_18
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The patterns of local failure in stage pN2 nonsmall-cell lung cancer (NSCLC) patients undergoing radical resection and adjuvant chemotherapy are controversial. Methods: The sites of local failure were compared in subgroups of patients with relevant clinicopathologic features (e.g., location and size of primary lesions). Results: Totally 75 patients with local failure after radical resection and adjuvant chemotherapy for pN2 NSCLC were included in the analysis. Thirty-seven (49.3%) patients had distant metastasis. The median duration from surgical resection to local failure was 11 months (range: 3-45 months). Sites with >= 10% failure rate in all subgroups based on the location of the primary lesions included 4R, 7, the ipsilateral hilum, and the stump. Additional sites with >= 10% failure rate included 2R, 2L, 4L, and 5 for lesions in the left upper lobe; 4L and 5 for lesions in the left lower lobe; and 2R and 3P for lesions in the right upper-middle lobe. Squamous cell carcinoma affected the stump failure rate compared to adenocarcinoma (56.3% vs. 18.0%, P = 0.003). Tumor diameter >= 5 cm affected the stump failure rate compared to tumor diameter < 5 cm (44.0% vs. 18.0%, P = 0.016). Skip N2 metastasis affected the ipsilateral hilum failure rate compared to nonskip N2 metastasis (7.5% vs. 31.4%, P = 0.008) Conclusions: For pN2 NSCLC patients undergoing radical resection and adjuvant chemotherapy, different lung lobes had different high-risk failure sites. Left lung cancer is prone to bilateral mediastinal lymph nodes recurrence, while right lung cancer mainly recurs with ipsilateral mediastinal lymph nodes. Moreover, the local failure patterns are influenced by pathological type, tumor size, and skip N2 metastasis.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 50 条
  • [41] Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery
    Feng, Po-Hao
    Yu, Chih-Teng
    Wu, Chin-Yang
    Lee, Meng-Jung
    Lee, Wei-Hwa
    Wang, Liang-Shun
    Lin, Shu-Min
    Fu, Jen-Fen
    Lee, Kang-Yun
    Yen, Tzung-Hai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2014, 6 (05): : 593 - 603
  • [42] Improving referral of patients for consideration of adjuvant chemotherapy after surgical resection of lung cancer
    Zuccato, J. A.
    Ellis, P. M.
    CURRENT ONCOLOGY, 2012, 19 (06) : E422 - E427
  • [43] Survival of Patients With Unsuspected pN2 Non-Small Cell Lung Cancer After an Accurate Preoperative Mediastinal Staging
    Obiols, Carme
    Call, Sergi
    Rami-Porta, Ramon
    Carlos Trujillo-Reyes, Juan
    Saumench, Roser
    Iglesias, Manuela
    Serra-Mitjans, Mireia
    Gonzalez-Pont, Guadalupe
    Belda-Sanchis, Jose
    ANNALS OF THORACIC SURGERY, 2014, 97 (03): : 957 - 964
  • [44] Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
    Dong, Lei
    Han, Zhao-feng
    Feng, Zi-hui
    Jia, Zhi-yang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (01) : 191 - 197
  • [45] Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer
    Sura, Karna
    Grills, Inga S.
    Vu, Charles C.
    Stevens, Craig W.
    Ye, Hong
    Guerrero, Thomas M.
    CLINICAL LUNG CANCER, 2018, 19 (02) : E185 - E194
  • [46] Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer
    De Craene, Sofie
    Surmont, Veerle
    van Meerbeeck, Jan P.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 102 - 111
  • [47] Invasiveness Diagnosis by Intraoperative Frozen Section Guides Resection Strategy Amomg 2cm NonSmall-Cell Lung Cancer
    Li, J.
    Feng, Y.
    Lu, X.
    Zhan, S.
    He, J.
    Liang, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S384 - S384
  • [48] A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: Final analysis
    Bardet, E
    Riviere, A
    Charloux, A
    Spaeth, D
    Ducolone, A
    LeGroumellec, A
    PellaeCosset, B
    HenryAmar, M
    Douillard, JY
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (01): : 163 - 168
  • [49] RETRACTED: Significance of Circulating Tumor Cells in Nonsmall-Cell Lung Cancer Patients: Prognosis, Chemotherapy Efficacy, and Survival (Retracted Article)
    Li, Jianpeng
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [50] Clinical Course After Radical Local Therapy for Oligo-Recurrence of Nonsmall Cell Lung Cancer
    Sonoda, Dai
    Maruyama, Raito
    Kondo, Yasuto
    Mitsuhashi, Shunsuke
    Tamagawa, Satoru
    Naito, Masahito
    Mikubo, Masashi
    Shiomi, Kazu
    Satoh, Yukitoshi
    JOURNAL OF SURGICAL ONCOLOGY, 2025,